Alterity Therapeutics (ADR) (ATHE)
Develops ATH434, a clinical candidate for multiple system atrophy and related Parkinsonian disorders.
$3.86
vs last close+0.08 (+2.12%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Feb '24Apr '24Aug '24Feb '25Feb '25Aug '25Feb '26Aug '26
Reported$0.00$0.00−$0.80$0.00$0.00−$0.34−$0.42−$0.05
Estimate−$0.14—−$0.07—−$0.69−$0.56−$0.25−$0.12
Surprise+98.1%—−1,067.4%—+99.9%+39.5%−65.9%+59.2%
RevenueReportedEstimate
Feb '24Apr '24Aug '24Feb '25Feb '25Aug '25Feb '26Aug '26
Reported$1.9M$1.1M$1.4M$803.0K$803.0K$4.1M$645.9K$806.6K
Estimate$958.3K—$910.1K—$2.3M$5.1M$1.1M$2.3M
Surprise+98.4%—+55.2%—−65.1%−18.0%−39.6%−65.2%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2027 | −$0.03 | — | — |
| Aug 2026 | −$0.12 | −$0.05 | +59.2% |
| Feb 2026 | −$0.25 | −$0.42 | −65.9% |
| Aug 2025 | −$0.56 | −$0.34 | +39.5% |
| Aug 2025 | — | — | — |
| Feb 2025 | −$0.69 | $0.00 | +99.9% |
| Feb 2025 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Jan 2024 | |||
| Aug 2023 | −$0.12 | — | — |
| Jun 2023 | |||
| Mar 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Feb 2022 | |||
| Dec 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Feb 2021 | |||
| Dec 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Feb 2020 | |||
| Dec 2019 | |||
| Aug 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Dec 2016 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Dec 2014 | |||
| Jun 2014 | |||
| Dec 2013 | |||
| Jun 2013 | |||
| Dec 2012 | |||
| Jun 2012 | |||
| Dec 2011 | |||
| Jun 2011 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 4, 2027 | −$0.03 | — | — | $800.8K | — | — | — |
| Aug 28, 2026 | −$0.12 | −$0.05 | +59.2% | $2.3M | $806.6K | −65.2% | −1.1% |
| Feb 25, 2026 | −$0.25 | −$0.42 | −65.9% | $1.1M | $645.9K | −39.6% | +2.9% |
| Aug 28, 2025 | −$0.56 | −$0.34 | +39.5% | $5.1M | $4.1M | −18.0% | +0.4% |
| Aug 4, 2025 | — | — | — | — | — | — | — |
| Feb 28, 2025 | −$0.69 | $0.00 | +99.9% | $2.3M | $803.0K | −65.1% | −2.3% |
| Feb 3, 2025 | |||||||
| Aug 29, 2024 | |||||||
| Apr 11, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Jan 30, 2024 | |||||||
| Aug 31, 2023 | −$0.12 | — | — | $1.5M | — | — | — |
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Aug 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Aug 31, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Aug 31, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Aug 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Dec 31, 2013 | |||||||
| Jun 30, 2013 | |||||||
| Dec 31, 2012 | |||||||
| Jun 30, 2012 | |||||||
| Dec 30, 2011 | |||||||
| Jun 30, 2011 |